IFP Advisors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
IFP Advisors's ATRC Position: Q2 2026 in Review
IFP Advisors increased its AtriCure (ATRC) stake by 1,404% in Q2 2026, buying an estimated $21.7K and bringing the position to 827 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2885.
IFP Advisors first reported a position in ATRC in Q4 2015 and has held it in 25 quarters since. The position peaked at $867K in Q2 2023. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- IFP Advisors held 827 shares of AtriCure worth $23.1K as of Q2 2026.
- IFP Advisors bought 772 AtriCure shares in Q2 2026, an estimated $21.7K.
- AtriCure made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2885 holding.
- IFP Advisors first reported a position in AtriCure in Q4 2015 and has held it in 25 quarters since.
- IFP Advisors's AtriCure position peaked at $867K in Q2 2023.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.